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of Flight Mass Spectrometry (MALDI-TOF
MS) and conventional methods in the
identification of clinically relevant bacteria
and yeast
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Abstract
Background: MALDI-TOF MS is an analytical method that has recently become integral in the identification of
microorganisms in clinical laboratories. It relies on databases that majorly employ pattern recognition or fingerprinting.
Biomarker based databases have also been developed and there is optimism that these may be superior to pattern
recognition based databases. This study compared the performance of ribosomal biomarker based MALDI-TOF MS and
conventional methods in the identification of selected bacteria and yeast.
Methods: The study was a cross sectional study identifying clinically relevant bacteria and yeast isolated from varied
clinical specimens submitted to a clinical laboratory. The identification of bacteria using conventional Vitek 2™
automated system, serotyping and MALDI-TOF MS was performed as per standard operating procedures.
Comparison of sensitivities were then carried out using Pearson Chi-Square test and p-value of <0.05 was
considered statistically significant. Secondary outcomes analyzed included the major and minor error rates.
Results: Of the 383 isolates MALDI-TOF MS and conventional methods identified 97.6 and 95.7% (p = 0.231) to
the genus level and 97.4 and 88.0% (p = 0.000) to the species level respectively. Biomarker based MALDI-TOF MS
was significantly superior to Vitek 2™ in the identification of Gram negative bacteria and Gram positive bacteria to
the species level. For the Gram positive bacteria, significant difference was observed in the identification of Coagulase
negative Staphylococci (p = 0.000) and Enterococcus (p = 0.008). Significant difference was also observed between
serotyping and MALDI-TOF MS (p = 0.005) and this was attributed to the lack of identification of Shigella species by
MALDI-TOF MS. There was no significant difference observed in the identification of yeast however some species of
Candida were unidentified by MALDI-TOF MS.
Conclusion: Biomarker based MALDI-TOF MS had good performance in a clinical laboratory setting with high
sensitivities in the identification of clinically relevant microorganisms.
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Background
Matrix Assisted Laser Desorption Ionization-Time of
Flight Mass Spectrometry (MALDI-TOF MS) is an ana-
lytical method developed in mid-1980s that has evolved
rapidly to fingerprint spectra for various microorganisms
including bacteria and fungi by analyzing protein profiles
[1–5]. Databases were subsequently developed and
adopted in clinical microbiology laboratories for the iden-
tification of clinically relevant microorganisms. These
databases employ the concept of pattern recognition or
fingerprinting where mass spectra obtained from a bac-
teria or yeast is compared to the existing spectra in the
databases to find the closest match [6, 7].
The biomarker approach to identification of bacteria
uses the specific proteins found within the bacterial cells.
Ribosomal proteins have turned out to be one of the
ideal biomarkers because they are abundant, highly con-
served and encoded by chromosomal genes. They also
have molecular masses that fall within the 4 to 30 kDa
range of MALDI-TOF MS [8]. Despite being highly con-
served there are inter-species and inter-strain differences
that can be employed in typing and sub-typing of micro-
organisms. Using ribosomal biomarkers Suarez et al.
were able to group various strains of Neisseria meningitidis
into six subgroups that corresponded to sequence types
and/or clonal complexes [9].
The Putative Assigned Protein Masses for Identifica-
tion Database (PAPMID™) (Mabritec AG, Switzerland) is
a biomarker based database that comprises molecular
masses of ribosomal proteins calculated from partial or
whole bacterial genome sequences. This database has
been shown to supplement pattern recognition reference
databases like the SARAMIS™ database [8]. Ziegler et al.
found that it performed as well as 16S rRNA sequencing
in the correct identification of root nodule bacteria [8].
This approach has also been shown to differentiate
strains of Acinetobacter Genomic species 13BJ/14TU
that are intrinsically resistant to polymixins from Acine-
tobacter haemolyticus [10]. This database therefore has
the ability to be an easily accessible and affordable alter-
native to gene sequencing especially for resource poor
settings in the developing world. We set out to com-
pare the sensitivity of biomarker based MALDI-TOF
MS to conventional methods like Vitek 2 and serotyping
in the identification of bacteria and yeast from a clinical
microbiology laboratory.
Methods
The study is a cross sectional study carried out at the
Aga Khan University Hospital, Nairobi, Kenya (AKUH,
N) and Mabritec laboratory, Riehen, Switzerland. Ethical
approval was granted by the AKUH, N’s Research and
Ethics Committee (Ref 2016/REC-06). Clinically relevant
bacteria and yeasts identified from clinical specimens
submitted to the AKUH, N laboratories were included in
the study. The specimens were given special codes and
delinked from patient identifiers throughout the study.
Only specimens classified as ‘UN3373 Biological Sub-
stances Cat B’ were shipped under ‘Dry Ice UN 1845’ for
the MALDI TOF analysis at Mabritec AG. Blinding was
maintained throughout the various stages of the study.
Processing of samples using Vitek 2™ and serotyping
The processing of the clinical specimen and identifica-
tion of bacteria using conventional Vitek 2™ automated
system was done at AKUH, N. Standard operating pro-
cedures (SOPs) in processing and culture of these speci-
mens were strictly adhered to and the organisms were then
put through the Vitek 2™ automated system for the final
biochemical identification. Serotyping was employed for
the identification of some isolates including Streptococcus,
Salmonella and Shigella species.
Processing of samples for MALDI TOF MS analyses
Freshly cultured isolates were spotted in duplicates dir-
ectly onto MALDI TOF target plates. The spots were then
overlaid with 1 ul of 25% formic acid and allowed to air
dry. They were then overlaid with 1 ul of matrix solution
consisting of 40 g of Alpha–cyano-4-hydroxycinnamic
acid (CHCA; Sigma-Aldrich, Buchs, Switzerland) in 33%
ethanol, 33% deionized water, 33% acetonitrile (ACN)
(Sigma-Aldrich) and 3% trifluoroacetic acid (TFA). For the
preparation of yeast, a formic acid suspension protocol
was used instead of direct smear. A colony of yeast was
picked using a 1 ul plastic inoculation loop and suspended
in 20 ul of 25% formic acid. One microliter of this suspen-
sion was then spotted onto the MALDI plate, allowed to
dry and then overlaid with the matrix. The matrix was
then allowed to dry in room air.
The MALDI plates were loaded onto the Axima™ Con-
fidence (Shimadzu-Biotech Corp., Kyoto, Japan) mass
spectrometer and mass spectra obtained in positive
linear mode at a frequency of 50 Hz and within mass
range of 3000 Da to 20,000 Da. Each MALDI plate was
externally calibrated using a spectra of reference strain
of Escherichia coli DH5α (Invitrogen, Carlsbad, USA)
that was also spotted onto the plates.
Data acquisition and analysis using SARAMIS™ and
PAPMID™
Empiric spectra for each spot was acquired and an average
of 50 to 100 protein mass fingerprints were processed
using the Launchpad™ 2.8 software (Shimadzu-Biotech).
The spectra were then analyzed using the Saramis™ data-
base and matched with the SuperSpectra™ to look for the
closest match. The spectra was then compared to the
PAPMID™ database to look for matches in species or
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strain specific ribosomal biomarkers. The closest match
was taken to be the identification of the microorganism.
Data analysis
Data collected were entered into Excel worksheets and
analyzed using SPSS version 23.0 (IBM; Armonk, New
York, USA). Comparison of sensitivities were then car-
ried out using Pearson Chi-Square test and P-value of
<0.05 was considered statistically significant. Secondary
outcomes analyzed include the major and minor error
rates reported in percentages.
Results
The 383 isolates recruited included 222 Gram negative
bacteria, 131 Gram positive bacteria and 30 yeast. Of all
the isolates, biomarker based MALDI-TOF MS identi-
fied 97.6% correctly to the genus level while the conven-
tional methods identified 95.7% to the genus level with a
p-value of 0.231. At the species level, 358 isolates were
analyzed. Of these, MALDI-TOF MS identified 97.4%
correctly while conventional methods identified only
88.0% correctly with a significant p-value of 0.000.
In Table 1 below the sensitivities of 195 Gram negative
bacteria identified using Vitek 2 and biomarker based
MALDI-TOF MS are shown. Of these, 100 and 92.3%
(p = 0.000) were correctly identified to the genus level
while 100 and 88.2% (p = 0.000) were correctly identified
to the species level by MALDI-TOF MS and Vitek 2™
respectively. Vitek 2 correctly identified 48 out of 55 E.
coli isolates to both the genus and species levels while
MALDI TOF MS identified all correctly with a signifi-
cant p-value of 0.006. Vitek 2™ misidentified four isolates
of E. coli as Serratia liquefaciens and Serratia fonticola.
The other three isolates of E. coli were misidentified as
Klebsiella pneumoniae, Pseudomonas aeruginosa and
Moraxella species. One isolate of E. coli was identified
correctly by both PAPMID™ database and Vitek 2™ while
SARAMIS™ database misidentified it as Shigella sonnei.
Table 1 Comparison of the sensitivities of Vitek 2 and MALDI-TOF MS in the identification of Gram negative bacteria to the species
and genus levels
Organism (n) Number (%) of isolates with Correct
identification to the species level:
Number (%) of isolates with Correct
identification to the genus level:
Vitek 2 MALDI-TOF MS P value Vitek 2 MALDI-TOF MS P value
E coli (55) 48 (87.3) 55 (100.0) 0.006 48 (87.3) 55 (100.0) 0.006
Klebsiella pneumoniae (33) 32 (97.0) 33 (100.0) 0.314 32 (97.0) 33 (100.0) 0.314
Klebsiella oxytoca (4) 3 (75.0) 4 (100.0) 0.285 4 (100.0) 4 (100.0)
Pseudomonas aeruginosa (14) 14 (100.0) 14 (100.0) 14 (100.0) 14 (100.0)
Pseudomonas mendocina (1) 0 (0.0) 1 (100.0) 1 (100.0) 1 (100.0)
Pseudomonas pseudoalcaligenes (1) 0 (0.0) 1 (100.0) 1 (100.0) 1 (100.0)
Acinetobacter baumannii (18) 18 (100.0) 18 (100.0) 18 (100.0) 18 (100.0)
Acinetobacter genomospecies 13BJ/14TU (1) 0 (0.0) 1 (100.0) 1 (100.0) 1 (100.0)
Acinetobacter ursingii (1) 1 (100.0) 1 (100.0) 1 (100.0) 1 (100.0)
Citrobacter freundii (6) 5 (83.3) 6 (100.0) 0.296 6 (100.0) 6 (100.0)
Citrobacter koseri (3) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0)
Enterobacter cloacae (12) 8 (66.7) 12 (100.0) 0.028 9 (75.0) 12 (100.0) 0.064
Enterobacter aerogenes (5) 5 (100.0) 5 (100.0) 5 (100.0) 5 (100.0)
Enterobacter gergoviae (1) 1 (100.0) 1 (100.0) 1 (100.0) 1 (100.0)
Haemophilus influenzae (4) 3 (75.0) 4 (100.0) 0.285 3 (75.0) 4 (100.0)
Morganella morganii (8) 7 (87.5) 8 (100.0) 0.302 8 (100.0) 8 (100.0)
Proteus mirabilis (7) 7 (100.0) 7 (100.0) 7 (100.0) 7 (100.0)
Proteus penneri/vulgaris (7) 6 (85.7) 7 (100.0) 0.299 7 (100.0) 7 (100.0)
Providencia rettgeri (1) 1 (100.0) 1 (100.0) 1 (100.0) 1 (100.0)
Stenotrophomonas maltophilia (10) 7 (70.0) 10 (100.0) 0.06 7 (70.0) 10 (100.0) 0.06
Serratia marcescens (1) 1 (100.0) 1 (100.0) 1 (100.0) 1 (100.0)
Vibrio alginolyticus (1) 1 (100.0) 1 (100.0) 1 (100.0) 1 (100.0)
Elizabethkingia meningoseptica (1) 1 (100.0) 1 (100.0) 1 (100.0) 1 (100.0)
Total (195) 172 (88.2) 195 (100.0) 0.000 180 (92.3) 195 (100.0) 0.000
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Of the Gram positive bacteria, 111 were identified rou-
tinely using Vitek 2™ while the rest were routinely identi-
fied using serotyping. Table 2 below shows the sensitivities
of Gram positive bacteria identified using Vitek 2™ and
MALDI-TOF MS. Of these, 100% were correctly identified
to both the genus and species levels by MALDI-TOF MS
while 99.1 and 83.8% were correctly identified to the
genus and species levels respectively by Vitek 2™ with a
significant P value of 0.000. All Staphylococcus species
were identified correctly to the genus level by both Vitek
2™ and MALDI-TOF MS. However, Vitek 2™ correctly
identified only 77.1% of Coagulase negative Staphylococcus
to the species level while MALDI-TOF MS identified all
correctly. All Enterococcus species were correctly identi-
fied to the species level by MALDI-TOF MS while Vitek
2™ identified only 72.7% correctly to the species level.
All the 18 Salmonella isolates were correctly identified
by both MALDI-TOF MS and serotyping to the genus
level. However, no comparison was performed at the
species level. All 9 Shigella isolates were misidentified as
E. coli by MALDI-TOF MS. All 20 Gram positive
bacteria, mainly Streptococcus species, were identified
correctly to the genus level by both MALDI-TOF MS
and Serotyping while only one was misidentified to the
species level by serotyping. Table 3 below shows the
sensitivities of serotyping and MALDI-TOF MS in the
identification of some Gram negative and Gram positive
bacteria routinely identified using serotyping.
Table 4 below shows the comparison of sensitivities of
biomarker based MALDI-TOF MS and Vitek 2™ in the
identification of yeasts. Of the 30 yeast isolates, 23
were correctly identified to the genus level by both
MALDI-TOF MS and Vitek 2™ while 23 and 22 were
identified correctly to the species level by MALDI-
TOF MS and Vitek 2™ respectively. Six isolates of
Candida haemulonii and 1 isolate of Candida guiller-
mondii that were unidentified by MALDI-TOF MS were
excluded from analysis.
Overall, MALDI-TOF MS had 2.6% minor errors while
conventional methods had 12.0% (p = 0.000). The major
errors were noted to be at 2.4 and 4.3% (p = 0.231) for
MALDI-TOF MS and conventional methods respect-
ively. No errors were made by MALDI-TOF in the iden-
tification of Gram positive bacteria in comparison to
16.2% (p = 0.000) minor errors and 0.9% (p = 0.316)
major errors noted for Vitek 2™. Vitek 2™ had 11.8%
Table 2 Comparison of the sensitivities of Vitek 2 and MALDI-TOF MS in the identification of Gram positive bacteria to the species
and genus levels
Organism (n) Number (%) of isolates with Correct
identification to the species level:
Number (%) of isolates with Correct
identification to the genus level:
Vitek 2 MALDI-TOF MS P value Vitek 2 MALDI-TOF MS P value
Staph aureus (33) 33 (100.0) 33 (100.0) 33 (100.0) 33 (100.0)
CoNS (48) 37 (77.1) 48 (100.0) 0.000 48 (100.0) 48 (100.0)
Staph capitis (3) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0)
Staph cohnii (1) 1 (100.0) 1 (100.0) 1 (100.0) 1 (100.0)
Staph epidermidis (10) 9 (90.0) 10 (100.0) 0.305 10 (100.0) 10 (100.0)
Staph hemolyticus (6) 3 (50.0) 6 (100.0) 0.046 6 (100.0) 6 (100.0)
Staph hominis (2) 2 (100.0) 2 (100.0) 2 (100.0) 2 (100.0)
Staph saprophyticus (23) 18 (78.3) 23 (100.0) 0.018 23 (100.0) 23 (100.0)
Staph sciuri (1) 1 (100.0) 1 (100.0) 1 (100.0) 1 (100.0)
Staph simulans (1) 0 (0.0) 1 (100.0) 1 (100.0) 1 (100.0)
Staph succinus (1) 0 (0.0) 1 (100.0) 1 (100.0) 1 (100.0)
Strep mitis/oralis (4) 3 (75.0) 4 (100.0) 0.285 4 (100.0) 4 (100.0)
Strep pneumoniae (3) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0)
Enterococcus (22) 16 (72.7) 22 (100.0) 0.008 21 (95.5) 22 (100.0)
Enterococcus avium (1) 1 (100.0) 1 (100.0) 1 (100.0) 1 (100.0)
Enterococcus faecalis (11) 9 (81.8) 11 (100.0) 0.138 10 (90.9) 11 (100.0) 0.306
Enterococcus faecium (7) 4 (57.1) 7 (100.0) 0.051 7 (100.0) 7 (100.0)
Enterococcus gallinarum (1) 1 (100.0) 1 (100.0) 1 (100.0) 1 (100.0)
Enterococcus hirae (2) 1 (50.0) 2 (100.0) 0.248 2 (100.0) 2 (100.0)
Aerococcus viridans (1) 1 (100.0) 1 (100.0) 1 (100.0) 1 (100.0)
Total (111) 93 (83.8) 111 (100.0) 0.000 110 (99.1) 111 (100.0) 0.316
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(p = 0.000) minor errors and 7.7% (p = 0.000) major
errors in the identification of Gram negative bacteria.
Discussion
MALDI TOF MS has been shown to reduce the turn-
around time, hospital stays and costs as compared to
biochemical based tests [11]. Thus far, the MALDI-TOF
MS databases introduced into clinical laboratories have
employed pattern recognition approaches in the identifi-
cation of microorganisms. In an attempt to improve sen-
sitivities, use of specific biomarkers rather than generic
non-conserved markers in the databases led to the con-
cept of biomarker based approach in identification [9].
The Putative Assigned Protein Masses for Identification
Database (PAPMID™) (Mabritec AG, Switzerland) is a bio-
marker based database that comprises molecular masses
of ribosomal proteins calculated from partial or whole
bacterial genome sequences [8].
Our study included an assortment of bacteria and
yeast isolated in a routine clinical laboratory using Vitek
2 and serotyping. Guo et al. showed an overall sensitivity
of 99.6 and 93.37% in the identification of bacteria to
the genus and species levels respectively [12]. The sensi-
tivity of biomarker based MALDI-TOF MS in the identi-
fication of Gram negative bacteria to the genus and
species level was 99 and 92% respectively. This was
significantly better than that of the conventional methods
including Vitek 2. Studies by Wang et al. show sensitivities
of pattern recognition MALDI TOF MS in the identifica-
tion of Gram negative bacteria ranging from 93.2 to 98.7%
[13]. Shigella species that had been identified routinely
using serotyping were all identified as E. coli by
MALDI-TOF MS. Studies have shown the difficulty in
discriminating these two species due to their close rela-
tionship [14–16]. All the Salmonella isolates were identi-
fied by MALDI-TOF MS as Salmonella enterica subsp.
enterica except one that was identified as Salmonella
species. No comparison was done at the species level as
serotyping identified serogroups as per the Kauffmann-
White Scheme while MALDI-TOF MS identified species
Table 3 Comparison of the sensitivities of serotyping and MALDI-TOF MS in the identification of selected bacteria to the species
and genus levels
Organism (n) Number (%) of isolates with Correct
identification to species level:
Number (%) of isolates with Correct
identification to genus level:
Serotyping MALDI-TOF MS P value Serotyping MALDI-TOF MS P value
Salmonella sp. (18) - - 18 (100.0) 18 (100.0)
Shigella flexneri (6) 6 (100.0) 0 0.001 6 (100.0) 0 0.001
Shigella sonnei (2) 2 (100.0) 0 0.046 2 (100.0) 0 0.046
Shigella dysentriae (1) 1 (100.0) 0 0.157 1 (100.0) 0 0.157
Strep agalactiae (13) 12 (92.3) 13 (100.0) 0.308 13 (100.0) 13 (100.0)
Strep pyogenes (7) 7 (100.0) 7 (100.0) 7 (100.0) 7 (100.0)
Total (29/47) 28 (96.6) 20 (69.0) 0.005 47 (100.0) 38 (80.9) 0.002
Table 4 Comparison of the sensitivities of Vitek 2 and MALDI-TOF MS in the identification of selected yeast to the species and genus
levels
Organism (n) Number (%) of isolates with Correct
identification to the species level:
Number (%) of isolates with Correct
identification to the genus level:
Vitek MALDI-TOF MS P value Vitek MALDI-TOF MS P value
Candida albicans (5) 5 5 5 5
Candida dubliniensis (2) 2 2 2 2
Candida glabrata (4) 4 4 4 4
Candida guillermondii (1)a - - - -
Candida haemulonii (6)a - - - -
Candida kefyr (1) 1 1 1 1
Candida krusei (4) 4 4 4 4
Candida parapsilosis (2) 2 2 2 2
Candida tropicalis (4) 3 4 0.285 4 4
Cryptococcus neoformans (1) 1 1 1 1
Total (23) 22 (95.7) 23 (100.0) 0.312 23 (100.0) 23 (100.0)
KEY: a6 isolates of Candida haemulonii and 1 isolate of Candida guillermondii have been excluded from analysis as they were not identified by MALDI-TOF MS.
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and subspecies [17]. Serological and biochemical tests
would still be recommended in confirmation of identifica-
tion of Salmonella and Shigella species [18]. An isolate of
Acinetobacter genomospecies 13BJ/14TU by PAPMID™
was identified by SARAMIS™ as Acinetobacter species and
as Acinetobacter baumannii by Vitek 2™. The Acinetobacter
genomospecies 13BJ/14TU have been shown to be
intrinsically resistant to colistin hence the significance
of correctly differentiating it from other Acinetobacter
species [10, 19].
In the overall identification of Gram positive bacteria to
the genus level, there was no significant difference in the
sensitivities between MALDI TOF MS and conventional
methods. However significant difference was observed in
the identification of these bacteria to the species level.
Coagulase negative Staphylococci (CoNS) were identified
to the species level with a sensitivity of 100% by biomarker
MALDI-TOF MS compared to 77.5% by Vitek 2™
(p = 0.000). This sensitivity was slightly better than that
shown by Zhou et al. where pattern recognition MALDI-
TOF MS identified 97.7% of CoNS correctly to the
species level compared to 76.0% by an automated bio-
chemical system [20]. The significance of correctly identi-
fying CoNS especially lies in the fact that they are the
commonest organisms found in positive blood cultures
and the need to rule out surface contamination and reduce
cost of unnecessary interventions [13, 20].
In the identification of Enterococcus, biomarker
MALDI-TOF MS correctly identified all to the species
level while Vitek 2™ identified only 72.7% correctly
(P = 0.008). There was no clinically significant difference
between the two methods in the identification of Entero-
coccus to the genus level. These findings mirror those of
previous studies that show excellent identification of En-
terococcus by MALDI-TOF MS especially in the discrim-
ination between E. faecalis and E. faecium due to their
significant differences in their resistance patterns [20, 21].
In the identification of Streptococcus, there was no
significant difference between biomarker MALDI-TOF
MS and Vitek 2™. However, 1 isolate of S. mitis/oralis was
misidentified as Streptococcus pneumoniae by Vitek 2™.
Studies had initially shown some difficulty in identification
between these two species that was attributed to lack of
extensive database [14, 22]. For Streptococcus pyogenes
and Streptococcus agalactiae, biomarker MALDI-TOF MS
was compared to serotyping which is conventionally
used in identification in our laboratory. Biomarker
MALDI-TOF MS correctly identified all to the genus
and species level while the serotyping misidentified 1 to
the species level.
In the identification of yeasts biomarker MALDI-TOF
MS performed as well as Vitek 2™ with sensitivity of
100.0 and 95.7% (p = 0.312) respectively. Both SARA-
MIS™ and PAPMID™ databases were unable to identify
one Candida guillermondii and six Candida haemulonii
isolates. This could be attributed to lack of spectra or
poor representation for these species in the databases.
Previous studies have shown the sensitivity of MALDI
TOF MS in the identification of yeasts to range from to
82.7 to 87.2%. In the cohort studied by Lohmann et al.
there was a single isolate of Candida haemulonii that
was not identified [6]. In various studies, Candida auris, an
emerging multidrug resistant organism, has been misiden-
tified as Candida haemulonii by Vitek 2 system [23–25].
This underscores the importance of incorporation of spec-
tra in the database for adequate discrimination between
these closely related species.
A limitation of the study is the few numbers in some
of the groups of microorganisms like Streptococcus pneu-
moniae, Cryptococcus and Candida species. Salmonella
typhi was not analysed since it did not meet the shipping
criteria. A larger study including these microorganisms
would yield more information on the performance of
biomarker based MALDI-TOF MS. We also recom-
mend studies on the performance of this biomarker
based database on direct identification from blood cul-
ture broths as recent studies have shown improved
clinical utility [26].
Conclusion
Our study has shown good performance of the biomarker
based approach in a clinical laboratory setting with high
sensitivities in the identification of clinically relevant
microorganisms. We recommend the adoption of this
approach in clinical laboratory settings to improve sensi-
tivities and to reduce the need for molecular testing.
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